Kaohsiung Medical University
Kaohsiung City, 807, Taiwan
NCT Number: NCT02996786
The aim of this study is to examine the beneficial effects of Danggui Buxue Tang on blood biochemical parameters in male recreational runners.
Looking for future studies?
Notify Me20 year–30 year
Male
Interventional
Not applicable
Kaohsiung City, 807, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Danggui Buxue Tang purchased from Kaiser Pharmaceutical
Consisting of corn starch and carboxymethyl cellulose
Time frame: Through study completion, an average of 1 year
Complete blood counts and serum haptoglobin and erythropoietin
Time frame: Through study completion, an average of 1 year
Serum iron, ferritin, transferrin and hepcidin
Time frame: Through study completion, an average of 1 year
Thiobarbituric acid reactive substances, superoxide dismutase, catalase, and glutathione peroxidase
Time frame: Through study completion, an average of 1 year
High-sensitivity c-reactive protein, Tumor necrosis factor-alpha, and interleukin-6
Time frame: Through study completion, an average of 1 year
The completion time for a 13-km run
Kaohsiung Medical University Chung-Ho Memorial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05707455
Sports Anemia
Cairo, Egypt
View Trial DetailsNCT06486623
Feeding and Eating Disorders, Female Athlete Triad
Poznan, Poland
View Trial DetailsNCT04401189
Behavior, Behavioral Symptoms
Aarhus, Denmark
View Trial DetailsNCT06437210
COVID-19, Chronic Disease
Bogotá, Bogotá DC, Colombia
View Trial Details